BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38225996)

  • 1. Immunohistochemical and Clinicopathological Characteristics of Invasive Breast Carcinoma in Nigeria.
    Wemimo RM; Eziagu UB; Sulaiman OA; Abiodun AE; Idowu NA; Ayinde AA; Taiwo AA
    Oman Med J; 2023 Sep; 38(5):e548. PubMed ID: 38225996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.
    Senel F
    Indian J Pathol Microbiol; 2021; 64(4):671-676. PubMed ID: 34673584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
    Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
    Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features.
    El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR
    Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Features of Triple Negative Breast Carcinoma.
    Reddy GM; Suresh PK; Pai RR
    J Clin Diagn Res; 2017 Jan; 11(1):EC05-EC08. PubMed ID: 28273970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome.
    Munawar S; Haider R; Ali SM; Yaqeen SR; Islam S; Asghar IA; Afzal A; Zia S; Irfan M; Hashmi AA
    Cureus; 2021 May; 13(5):e15006. PubMed ID: 34150374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
    Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
    Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of molecular breast cancer subtypes among Tunisian women and correlation with histopathological parameters: a study of 194 patients.
    Ben Abdelkrim S; Trabelsi A; Missaoui N; Beizig N; Bdioui A; Anjorin A; Jomaa W; Mokni M
    Pathol Res Pract; 2010 Nov; 206(11):772-5. PubMed ID: 20850937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association between Molecular Subtypes of Breast Cancer with Histological Grade and Lymph Node Metastases in Indonesian Woman.
    Setyawati Y; Rahmawati Y; Widodo I; Ghozali A; Purnomosari D
    Asian Pac J Cancer Prev; 2018 May; 19(5):1263-1268. PubMed ID: 29801411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Molecular Subtypes of Breast Carcinoma and Its Comparison between Two Different Age Groups: A Retrospective Study from a Tertiary Care Center of Northeast India.
    Sharma JD; Khanna S; Ramchandani S; Kakoti LM; Baruah A; Mamidala V
    South Asian J Cancer; 2021 Dec; 10(4):220-224. PubMed ID: 34984199
    [No Abstract]   [Full Text] [Related]  

  • 14. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
    Mohapatra M; Sarma YS
    J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
    Choi Y; Kim EJ; Seol H; Lee HE; Jang MJ; Kim SM; Kim JH; Kim SW; Choe G; Park SY
    Hum Pathol; 2012 Jan; 43(1):48-55. PubMed ID: 21733550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis.
    Ch'ng ES; Tuan Sharif SE; Jaafar H
    Asian Pac J Cancer Prev; 2012; 13(9):4445-52. PubMed ID: 23167359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.
    Sánchez-Muñoz A; Vicioso L; Santonja A; Álvarez M; Plata-Fernández Y; Miramón J; Zarcos I; Ramírez-Tortosa CL; Montes-Torres J; Jerez JM; de Luque V; Llácer C; Fernández-De Sousa CE; Pérez-Villa L; Alba E
    Mod Pathol; 2018 Feb; 31(2):299-306. PubMed ID: 28984296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.
    Akbar M; Akbar K; Naveed D
    J Ayub Med Coll Abbottabad; 2014; 26(3):290-3. PubMed ID: 25671929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.
    Sun WY; Choi J; Cha YJ; Koo JS
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria.
    Liman AA; Kabir B; Abubakar M; Abdullahi S; Ahmed SA; Shehu SM
    Niger J Clin Pract; 2022 Jan; 25(1):97-104. PubMed ID: 35046202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.